Get the Stockscreener App
1.73
4.95%
-0.09
After Hours:
1.72
-0.01
-0.58%
Intelligent Bio Solutions Inc stock is traded at $1.73, with a volume of 133.63K.
It is down -4.95% in the last 24 hours and up +22.70% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana.
See More
Previous Close:
$1.82
Open:
$1.81
24h Volume:
133.63K
Relative Volume:
0.08
Market Cap:
$7.35M
Revenue:
$2.46M
Net Income/Loss:
$-13.40M
P/E Ratio:
-0.1785
EPS:
-9.69
Net Cash Flow:
$-7.34M
1W Performance:
+0.58%
1M Performance:
+22.70%
6M Performance:
-59.00%
1Y Performance:
-86.00%
1-Day Range:
$1.71
$1.83
1-Week Range:
$1.70
$2.00
52-Week Range:
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-233-6971
Address
135 W 41ST ST,, NEW YORK
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Intelligent Bio Solutions grants stock awards to top executives By Investing.com - Investing.com Canada
Intelligent Bio Solutions grants stock awards to top executives - Investing.com
Intelligent Bio Solutions grants stock awards to top executives - Investing.com India
Intelligent Bio Solutions completes key FDA study phase By Investing.com - Investing.com Canada
Intelligent Bio Solutions Incentivizes Executives with Stock Awards - TipRanks
Intelligent Bio Solutions grants stock awards to top executives By Investing.com - Investing.com UK
Intelligent Bio Solutions Nears FDA Submission with Test Success - TipRanks
Intelligent Bio : Concludes In Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission Form 8 K - Marketscreener.com
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission - ForexTV.com
Intelligent Bio Solutions completes key FDA study phase - Investing.com
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission - The Manila Times
Intelligent Bio Solutions completes key FDA study phase By Investing.com - Investing.com UK
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission - StockTitan
Intelligent Bio announces Thanet Earth adopted its Fingerprint Drug Test - TipRanks
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to - EIN News
Intelligent Bio Solutions Full Year 2024 Earnings: Misses Expectations - Simply Wall St
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Intelligent Bio Solutions reports FY24 EPS ($6.38) vs. ($127.00) last year - TipRanks
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights - Marketscreener.com
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results and Operational Highlights - StockTitan
INTELLIGENT BIO SOLUTIONS INC. SEC 10-K Report - TradingView
Intelligent Bio Solutions announces $3 million stock offering By Investing.com - Investing.com Canada
Intelligent Bio Solutions announces $3 million stock offering - Investing.com
Stocks Driving Market Momentum with Groundbreaking Contracts and Technologies: LUNR, PRSO, LPTH, INBS, PNPN.V | FinancialContent Business Page - Financial Content
Holdings of Intelligent Bio Solutions Inc (INBS) are aligned with the stars - SETE News
Upward Trajectory: Intelligent Bio Solutions Inc (INBS) Posts a Gaine, Closing at 2.48 - The Dwinnex
Intelligent Bio Solutions Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
Technical analysis of Intelligent Bio Solutions Inc (INBS) stock chart patterns - US Post News
New Outlook On Intelligent Bio Solutions Inc - Stocks Register
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024 - EIN News
Quarterly Snapshot: Quick and Current Ratios for Intelligent Bio Solutions Inc (INBS) - The Dwinnex
Intelligent Bio Solutions Inc (NASDAQ: INBS) Down -89.80% This Year: What Is Going To Happen Next - Stocks Register
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024 - StockTitan
There is no doubt that Intelligent Bio Solutions Inc (INBS) ticks all the boxes. - SETE News
Penny stocks analysis: AITX, Intelligent Bio (INBS), Tonix (TNXP) - Invezz
Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher - Benzinga
"Intelligent Bio (NASDAQ: INBS), SINTX Technologies (NASDAQ: - openPR
"Stocks to Watch Showing Strong Market Potential INBS, NANO.T, MLGO, KAVL, PNPN.V" - Marketscreener.com
INBS’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Intelligent Bio (INBS) Stock Rallies On Strong Financial Performance - Stocks Telegraph
What's Going On With Opiate Screening Tests-Focused Intelligent Bio Solutions Stock On Monday? - Benzinga
US Stocks Higher; Dow Surges Over 200 Points - Benzinga
Intelligent Bio Solutions reports Q4 rvenue $0.73M, up 64% year-over-year - TipRanks
Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y - MSN
Intelligent Bio Solutions Inc. Announces Preliminary Full Fiscal Year 2024 Revenue Growth of 148% Year-Over-Year - Nasdaq
Intelligent Bio Solutions Inc (INBS) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Intelligent Bio Solutions Advances in FDA Approval Process - TipRanks
Intelligent Bio announces progress to plan required for FDA 510k submission - TipRanks
Intelligent Bio Solutions Inc. Announces Progress Toward Completion of Clinical Study Plan Required for FDA 510(k) Submission - StockTitan
Fit to Work: Intelligent Bio Solutions' (NASDAQ - Marketscreener.com
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):